Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -43.03% | 50.45% | 83.45% | 66.16% | 113.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.04% | 53.60% | 129.79% | 45.30% | 89.64% |
| Operating Income | -1.04% | -53.60% | -129.79% | -45.30% | -89.64% |
| Income Before Tax | 12.86% | -54.84% | -125.15% | -60.80% | -150.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.86% | -54.84% | -125.15% | -60.80% | -150.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.86% | -54.84% | -125.15% | -60.80% | -150.33% |
| EBIT | -1.04% | -53.60% | -129.79% | -45.30% | -89.64% |
| EBITDA | -0.98% | -53.51% | -- | -- | -- |
| EPS Basic | 19.34% | -0.36% | -1,102.56% | 25.41% | -48.92% |
| Normalized Basic EPS | 19.51% | -23.11% | -13.66% | 16.87% | -34.27% |
| EPS Diluted | 19.34% | -0.36% | -1,102.56% | 25.41% | -48.92% |
| Normalized Diluted EPS | 19.51% | -23.11% | -13.66% | 16.87% | -34.27% |
| Average Basic Shares Outstanding | 8.28% | 25.81% | 98.16% | 93.31% | 86.31% |
| Average Diluted Shares Outstanding | 8.28% | 25.81% | 98.16% | 93.31% | 86.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |